Isotracin

Isotretinoin, the active ingredient in Isotracin, is a retinoid presented as an oral tablet for oral use. It treats severe nodular acne and acne vulgaris in patients who require systemic therapy. Isotretinoin works by targeting the underlying mechanisms of acne, offering a potent option when topical treatments are insufficient.

GNH USA supplies Isotracin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotracin is a retinoid indicated for severe forms of acne that involve the pilosebaceous unit. - Severe nodular acne: reduces lesion count and prevents formation of new nodules. - Acne vulgaris: decreases inflammatory lesions and improves overall skin appearance. - Moderate to severe acne: provides systemic control when topical therapy alone is inadequate.

Isotracin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Photosensitivity. - Elevated liver enzymes. - Increased triglyceride levels. - Musculoskeletal discomfort.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease flare. - Pseudotumor cerebri (intracranial hypertension). - Teratogenic effects leading to birth defects. - Severe hypercalcemia. - Pancreatitis.

Before initiating Isotracin, several safety considerations are recommended. - Pregnancy: contraindicated due to high teratogenic risk. - Breastfeeding: not recommended because drug may be secreted in milk. - Baseline labs: monitor liver function and lipid profile before and during therapy. - Sun exposure: avoid excessive UV exposure as photosensitivity may increase. - Vitamin A supplements: avoid concurrent use to prevent additive toxicity. - Store at ambient temperature: keep in original container, protect from moisture and light.

Isotracin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Systemic corticosteroids: may diminish isotretinoin efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced effectiveness; advise alternative contraception. - Macrolide antibiotics: may raise isotretinoin plasma levels. - Antifungal agents (e.g., ketoconazole): may increase serum concentrations.